Clinical Trial Update: Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC [Phase 1]

View source ↗

Summary

Phase 1 study evaluating prophylactic CD45RA-depleted donor lymphocyte infusion after haploidentical transplantation with reduced-intensity conditioning; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Drugs mentioned

• CD45RA-depleted donor lymphocyte infusion

Snippet

Sponsor: University Hospital, Geneva | Conditions: Hematologic Malignancy, Haplo-identical Stem Cell Transplantation | Phase 1 | Status: RECRUITING